Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT / Sp1 / MMP1 axis
Environmental Toxicology · 2024-07 · 39 (7) · 3920-3929
DOI: 10.1002/tox.24246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 03.04.2024. Verfasst von Yat-Yin Law und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chung Shan Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Osteosarcoma, Cell Movement, Pentacyclic Triterpenes, Matrix Metalloproteinase 1. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Changhua Christian Hospital.
Abstract (Originalsprache)
Osteosarcoma is a malignant bone tumor affecting adolescents and children. No effective treatment is currently available. Asiatic acid (AA), a triterpenoid compound found in Centella asiatica , possesses anti‐tumor, anti‐inflammatory, and anti‐oxidant properties in various types of tumor cells. This study aims to determine whether AA exerts antitumor effects in human osteosarcoma cells. Our results indicate that AA does not influence the viability, proliferative rate, or cell cycle phase of human osteosarcoma cells under non‐toxic conditions. AA suppressed osteosarcoma cell migration and invasion by down‐regulating matrix metalloproteinase 1 (MMP1) expression. Data in the TNMplot database suggested MMP1 expression was higher in osteosarcoma than in normal tissues, with associated clinical significance observed in osteosarcoma patients. Overexpression of MMP1 in osteosarcoma cells reversed the AA‐induced suppression of cell migration and invasion. AA treatment decreased the expression of specificity protein 1 (Sp1), while Sp1 overexpression abolished the effect of AA on MMP1 expression and cell migration and invasion. AA inhibited AKT phosphorylation, and treatment with a PI3K inhibitor (wortmannin) increased the anti‐invasive effect of AA on osteosarcoma cells via the p‐AKT/Sp1/MMP1 axis. Thus, AA exhibits the potential for use as an anticancer drug against human osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Division of Neurosurgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan.
ORCID-Profile: Pei-Ni Chen, Yi-Hsien Hsieh
Förderung
- Changhua Christian Hospital
Zitieren
APA
Law, Y. Y., Lee, H. L., Lin, C. L., Chen, P. N., Wang, P. H., Hsieh, Y. H., & Chen, C. M. (2024). Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT / Sp1 / MMP1 axis. Environmental Toxicology, 39(7), 3920-3929. https://doi.org/10.1002/tox.24246
Vancouver
Law YY, Lee HL, Lin CL, Chen PN, Wang PH, Hsieh YH, et al. Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT / Sp1 / MMP1 axis. Environmental Toxicology. 2024;39(7):3920-3929. doi:10.1002/tox.24246
BibTeX
@article{Law2024,
author = {Law, Yat-Yin and Lee, Hsiang-Lin and Lin, Chu-Liang and Chen, Pei-Ni and Wang, Pei-Han and Hsieh, Yi-Hsien and Chen, Chien-Min},
title = {Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT / Sp1 / MMP1 axis},
journal = {Environmental Toxicology},
year = {2024},
volume = {39},
number = {7},
pages = {3920--3929},
doi = {10.1002/tox.24246}
}
EUVIMED